北米の子宮内避妊器具市場

【英語タイトル】North American Intrauterine Contraceptive Devices (IUCD) Market by Type (Female Contraceptive devices, Male Contraceptive devices) - Forecast to 2019

MicroMarketMonitorが出版した調査資料(MMM-IN-1000)・商品コード:MMM-IN-1000
・発行会社(調査会社):MicroMarketMonitor
・発行日:2015年2月6日
・ページ数:70
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:北米
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,650 ⇒換算¥288,850見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD4,505 ⇒換算¥491,045見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、北米の子宮内避妊器具市場について調査・分析し、エグゼクティブサマリー、市場概観、成長要因・阻害要因、市場環境分析、種類別分析、主要国別分析、市場規模及び予測、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

The North America intrauterine contraceptive devices market is estimated to grow at a CAGR of 0.3% from 2014 to 2019. The growth of the intrauterine contraceptive devices market is driven by factors such as increasing rate of unplanned pregnancies, effective contraception and less side effects of IUCD, implementation of the Affordable Care Act (ACA), rising initiatives of private firms directed towards reducing expenses related to abortion, funds/grants for IUCD products, and technological advancements. However, high costs of treatment, threat of pelvic inflammatory infection (PID), threat of ectopic pregnancy, high rate of complications during unplanned pregnancy, and the need for compulsory assistance of medical professionals hamper the growth of the IUCD market. Moreover, the rising number of players in this segment and technological advancements create growth opportunities for the North America intrauterine contraceptive devices market in these regions.

In this report, the North America intrauterine contraceptive devices market has been broadly classified on the basis of types, which includes Hormonal IUCD and Copper IUCD. The hormonal IUCD market segment accounted for the largest market share of 83.4% of the North American intrauterine contraceptive devices market. Factors such as safety, easy removal, lighter periods, and the increasing adoption of hormonal IUD products such as Mirean and Skyla in the U.S. drive the growth of this market.

Geographically, the U.S. is estimated to command the largest share of 93.0% of the North America intrauterine contraceptive devices market in 2014, followed by Canada. The intrauterine contraceptive devices market in the U.S. is primarily driven by the Affordable Care Act and technological advancements. However, stringent regulatory and reimbursement policies in the U.S. and the threat of PID infection hamper the growth of the intrauterine contraceptive devices market in this region.

The North America intrauterine contraceptive devices market is a competitive market with a number of market players. As of 2014, the North America intrauterine contraceptive devices market is estimated to be dominated by Bayer HealthCare AG (A subsidiary of BAYER AG) (Germany), Teva Pharmaceuticals Industries Ltd. (Israel), Actavis Plc. (Ireland), and Medicines360 (Ireland). New product launches & partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most market players to achieve growth in the North America intrauterine contraceptive devices market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis—market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging- and high-growth segments of the North America intrauterine contraceptive devices market, high-growth regions & countries & their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.

The report will enrich both the established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms garner a greater market share. Firms that purchase the report could use any one or a combination of five strategies that include market penetration, product development/innovation, market development, market diversification, and competitive assessment to strengthen their market share.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on intrauterine contraceptive devices offered by top players in the North America intrauterine contraceptive devices market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the North America intrauterine contraceptive devices market.
• Market Development: Comprehensive information of lucrative emerging markets. The report analyzes the markets for various intrauterine contraceptive devices across geographies.
• Market Diversification: Exhaustive information of new products, untapped geographies, recent developments, and investments in the North America intrauterine contraceptive devices market.
• Competitive Assessment: In-depth assessment of the market shares, strategies, products, and manufacturing capabilities of leading players in the North America intrauterine contraceptive devices market.

【レポートの目次】

Table Of Contents

1 Introduction 18
1.1 Objectives Of The Study 18
1.2 Market Segmentation & Coverage 19
1.3 Stakeholders 20

2 Research Methodology 21
2.1 Integrated Ecosystem Of Laboratory Information System (Lis) Market 21
2.2 Arriving At The Laboratory Information System (Lis) Market Size 22
2.2.1 Top-Down Approach 22
2.2.2 Macroindicator-Based Approach 23
2.3 Assumptions 24

3 Executive Summary 25

4 Market Overview 28
4.1 Introduction 28
4.2 Laboratory Information Systems(Lis) Market: Comparison With Clinical Information Systems (Cis) Market 29
4.3 Market Drivers And Inhibitors 30
4.4 Key Market Dynamics 31

5 North American Laboratory Information System Market, By Product 38
5.1 Introduction 39
5.2 North America Laboratory Information System Products Market: Comparison With Clinical Information Systems Market, 2013–2019 (Usd Million) 40
5.3 North American Standalone Laboratory Information Systems Market, By Geography 42
5.4 North American Integrated Laboratory Information Systems Market, By Geography 43

6 North America Laboratory Information System Market, By Type 45
6.1 Introduction 46
6.2 North America Laboratory Information System Type Market: Comparison With Clinical Information Systems (Cis) Market 47
6.3 North America Clinical Pathology Market, By Geography 48
6.4 North America Anatomical Pathology Market, By Geography 49

7 North American Laboratory Information System Market, By Component 50
7.1 Introduction 51
7.2 North America Laboratory Information System Components Market: Comparison With Clinical Information Systems (Cis) Market 52
7.3 North America Laboratory Information System Services Market, By Geography 53
7.4 North America Laboratory Information System Software Market, By Geography 54

8 North America Laboratory Information System Market, By Delivery Mode 55
8.1 Introduction 56
8.2 North America Laboratory Information System Delivery Modes Market: Comparison With Clinical Information Systems (Cis) Market 57
8.3 North America On-Premise Laboratory Information System Market, By Geography 58
8.4 North America Remotely-Hosted Laboratory Information System Market, By Geography 59
8.5 North America Cloud-Based Laboratory Information System Market, By Geography 60

9 North America Laboratory Information System Market, By End-User 62
9.1 Introduction 63
9.2 North America Laboratory Information System End-Users Market: Comparison With Clinical Information Systems (Cis) Market 65
9.3 North America Clinical Diagnostic Laboratories Information System Market, By Geography 66
9.4 North America Hospitals Laboratory Information System Market, By Geography 67
9.5 North America Anatomical Pathology Laboratory Information System Market, By Geography 68
9.6 North America Blood Banks Laboratory Information System Market, By Geography 69
9.7 North America Molecular Diagnostic Laboratory Information System Market, By Geography 70
9.8 North America Others Laboratory Information System Market, By Geography 71

10 North American Laboratory Information Systems Market, By Geography 72
10.1 Introduction 73
10.2 U.S. Laboratory Information Systems Market 74
10.2.1 U.S. Laboratory Information Systems Market, By Product 77
10.2.2 U.S. Laboratory Information Systems Market, By Type 78
10.2.3 U.S. Laboratory Information System Market, By Component 79
10.2.4 U.S. Laboratory Information System Market, By Delivery Mode 80
10.2.5 U.S. Laboratory Information System Market, By End-User 81
10.3 Canada Laboratory Information Systems Market 82
10.3.1 Canada Laboratory Information System Market, By Product 84
10.3.2 Canada Laboratory Information System Market, By Type 85
10.3.3 Canada Laboratory Information System Market, By Component 86
10.3.4 Canada Laboratory Information System Market, By Delivery Mode 87
10.3.5 Canada Laboratory Information System Market, By End-User 89
10.4 Mexico Laboratory Information System Market 90
10.4.1 Mexico Laboratory Information System Market, By Product 92
10.4.2 Mexico Laboratory Information System Market, By Type 93
10.4.3 Mexico Laboratory Information System Market, By Component 94
10.4.4 Mexico Laboratory Information System Market, By Delivery Mode 96
10.4.5 Mexico Laboratory Information System Market, By End-User 97

11 North America Laboratory Information System Market: Competitive Landscape 99
11.1 North America Laboratory Information System Market: Company Share Analysis 99
11.2 Company Presence In Laboratory Information System Market, By Type 100
11.3 Mergers & Acquisitions 101
11.4 Expansions 103
11.5 Agreements 103
11.6 Collaborations 103
11.7 Partnership 104
11.8 New Product Launches 105

12 North American Laboratory Information Systems Market, By Company 107
12.1 Epic Systems Corporation 107
12.1.1 Overview 107
12.1.2 Key Financials: 107
12.1.3 Product And Service Offerings 107
12.1.4 Related Developments 108
12.1.5 Mmm Analysis 108
12.2 Mckesson Corporation 109
12.2.1 Overview 109
12.2.2 Key Financials 110
12.2.3 Product And Service Offerings 110
12.3 Related Developments 111
12.3.1 Mmm Analysis 111
12.4 Medical Information Technology, Inc. 113
12.4.1 Overview 113
12.4.2 Key Financials 114
12.4.3 Product And Service Offerings 114
12.4.4 Related Developments 115
12.4.5 Mmm Analysis 115
12.5 Scc Soft Computer 116
12.5.1 Overview 116
12.5.2 Key Financials 116
12.5.3 Product And Service Offerings 116
12.5.4 Related Developments 116
12.5.5 Mmm Analysis 117
12.6 Compugroup Medical Ag 118
12.6.1 Overview 118
12.6.2 Key Financials 119
12.6.3 Product And Service Offerings 119
12.6.4 Related Developments 120
12.6.5 Mmm Analysis 120
12.7 Computer Programs And Systems, Inc. 121
12.7.1 Overview 121
12.7.2 Key Financials 122
12.7.3 Product And Service Offerings 122
12.7.4 Related Developments 123
12.7.5 Mmm Analysis 123
12.8 Merge Healthcare Incorporated 124
12.8.1 Overview 124
12.8.2 Key Financials 125
12.8.3 Product Offerings 125
12.8.4 Related Developments 126
12.8.5 Mmm Analysis 126
12.9 Orchard Software Corporation 127
12.9.1 Overview 127
12.9.2 Key Financials 127
12.9.3 Product And Service Offerings 127
12.9.4 Related Developments 127
12.9.5 Mmm Analysis 128
12.10 Hex Labs 129
12.10.1 Overview 129
12.10.2 Key Financials 129
12.10.3 Product And Service Offerings 129
12.10.4 Related Developments 129
12.10.5 Mmm Analysis 129
12.11 Comp Pro Med 130
12.11.1 Overview 130
12.11.2 Key Financials 130
12.11.3 Product And Service Offerings 130
12.11.4 Related Developments 130
12.11.5 Mmm Analysis 131
12.12 Cerner Corporation 132
12.12.1 Overview 132
12.12.2 Key Financials 133
12.12.3 Product And Service Offerings 133
12.12.4 Related Developments 134
12.12.5 Mmm Analysis 135
12.13 Sunquest Information Systems, Inc. (Subsidiary Of Roper Industries) 136
12.13.1 Overview 136
12.13.2 Key Financials 137
12.13.3 Product And Service Offerings 138
12.13.4 Related Developments 138
12.13.5 Mmm Analysis 139
12.14 Allscripts 140
12.14.1 Overview 140
12.14.2 Key Financials 141
12.14.3 Product And Service Offerings 141
12.14.4 Related Developments 142
12.14.5 Mmm Analysis 142
12.15 Quest Diagnostics Incorporated. 143
12.15.1 Overview 143
12.15.2 Key Financials 144
12.15.3 Product And Service Offerings 144
12.15.4 Related Developments 145
12.15.5 Mmm Analysis 145

13 Appendix 146
13.1 Customization Options 146
13.1.1 Porter’S Five Forces Analysis 146
13.1.1.1 Threat From New Entrants 146
13.1.1.2 Bargaining Power Of Suppliers 146
13.1.1.3 Bargaining Power Of Buyers 147
13.1.1.4 Threat From Substitutes 147
13.1.1.5 Intensity Of Competitive Rivalry 147
13.2 Related Reports 148
13.3 Introducing Rt: Real-Time Market Intelligence 148
13.3.1 Rt Snapshots 149

List Of Tables

Table 1 North America Intra-Uterine Contraceptive Devices Market: Macro Indicators, By Country, 2013 (Abortion Per 1000 Women Ages 15-44) 14
Table 2 North America Intra-Uterine Contraceptive Devices Market: Drivers And Inhibitors 19
Table 3 Global Intra-Uterine Contraceptive Devices Market: Comparision With Global Female Contraceptives Market, 2013–2019 (USD MN) 23
Table 4 North America Intra-Uterine Contraceptive Devices Market, By Country, 2013–2019 (USD MN) 24
Table 5 North America Intra-Uterine Contraceptive Devices Market, By Typ,
2013–2019 (USD MN) 25
Table 6 North America Intra-Uterine Contraceptive Devices Market, By Type,
2013–2019 (USD MN) 29
Table 7 North America Intra-Uterine Contraceptive Devices Market: Type Comparison With Female Contraceptives Market, 2013–2019 (USD MN) 30
Table 8 North America Hormonal Iud Market, By Country, 2013–2019 (USD MN) 30
Table 9 North America Copper Iud Market, By Country, 2012 - 2018 (USD MN) 31
Table 10 North America Intra-Uterine Contraceptive Devices Market, Bycountry, 2012 - 2018 (USD MN) 43
Table 11 North America Intra-Uterine Contraceptive Devices Market, By Type,
2012 - 2018 (USD MN) 43
Table 12 U.S. Intra-Uterine Contraceptive Devices Market, By Type,
2013-2019 (USD MN) 48
Table 13 Canada Intra-Uterine Contraceptive Devices Market, By Type,
2012 - 2018 (USD MN) 50
Table 14 U.S. Intra-Uterine Contraceptive Devices Market: Company Share Analysis, 2013 (%) 51
Table 15 Canada Intra-Uterine Contraceptive Devices Market: Company Share Analysis, 2013 (%) 52
Table 16 North America Intra-Uterine Contraceptive Devices Market: Mergers & Acquisitions 53
Table 17 North America Intra-Uterine Contraceptive Devices Market: Regulatory Approvals 53
Table 18 North America Intra-Uterine Contraceptive Devices Market: Partnership 54
Table 19 North America Intra-Uterine Contraceptive Devices Market: Collaboration 54
Table 20 Bayer Healthcare Ag.: Key Financials, 2008 - 2013 (USD MN) 56
Table 21 Teva Pharmaceutical Industries Ltd.: Key Financials, 2008 - 2013 (USD MN) 59
Table 22 Actavis Plc: Key Financials, 2008 - 2013 (USD MN) 62

List Of Figures

Figure 1 Evolution Of Iucd 8
Figure 2 Widely Used Contraceptive Methods 9
Figure 3 North America Intra-Uterine Contraceptive Devices Market: Segmentation & Coverage 10
Figure 4 Intrauterine Contraceptive Devices Market: Integrated Ecosystem 11
Figure 5 Top-Down Approach 12
Figure 6 Bottom-Up Approach 13
Figure 7 Macro Indicator-Based Approach 14
Figure 8 North America Intra-Uterine Contraceptive Devices Market Snapshot 17
Figure 9 Birth Control Methods Covered Under Affordable Care Act (Aca) 19
Figure 10 Global Intrauterine Contraceptive Devices Market: Comparison With Global Female Contraceptives Market 23
Figure 11 North America Intrauterine Contraceptive Devices, By Country,
2013 (USD MN) 24
Figure 12 North America Intrauterine Contraceptive Devices Market, By Type,
2013 (USD MN) 25
Figure 13 Advantages And Disadvantages Of Copper Iucd 27
Figure 14 Advantages And Disadvantages Of Hormonal Iucd 28
Figure 15 North America Intra-Uterine Contraceptive Devices Market, By Type,
2012 - 2018 (USD MN) 28
Figure 16 North America Intra-Uterine Contraceptive Devices Market: Type Comparison With Female Contraceptives Market, 2013–2019 (USD MN) 29
Figure 17 North America Hormonal Iud Market, By Country, 2013–2019 (USD MN) 30
Figure 18 North America Copper Iud Market, By Country, 2013–2019 (USD MN) 31
Figure 19 Sales (USD Million) Of Mirena, U.S., 2012 32
Figure 20 Adverse Effects Caused By Mirena, U.S., 1997-2012 33
Figure 21 Product Comparison Between Mirena And Skyla, U.S. 36
Figure 22 Product Specifications, Levosert 41
Figure 23 Average Selling Price (Usd) Of Marketed Intra-Uterine Contraceptive Devices (Iucd) In U.S. And Canada, 2013 44
Figure 24 U.S. Intra-Uterine Contraceptive Devices Market Overview,
2014 & 2019 (USD MN) 46
Figure 25 U.S. Intra-Uterine Contraceptive Devices Market, By Type 2013-2019 (USD MN) 47
Figure 26 Percentage Usage Of Various Contraceptive Devices , U.S., 2010 47
Figure 27 Percentage Usage Of Various Contraceptive Devices , U.S., 2013 48
Figure 28 Canada Intra-Uterine Contraceptive Devices Market Overview,
2013 & 2018 (%) 49
Figure 29 Canada Intra-Uterine Contraceptive Devices Market, By Type,
2012-2018 (USD MN) 50
Figure 30 U.S. Intra-Uterine Contraceptive Devices Market: Company Share Analysis, 2013 (%) 51
Figure 31 Canada Intra-Uterine Contraceptive Devices Market: Company Share Analysis, 2013 (%) 52
Figure 32 Bayer Healthcare Ag: Revenue Mix (2013) (%) 55
Figure 33 Contribution Of Pharmaceuticals Segment Towards Company Revenues, 2008-2013 (USD MN) 56
Figure 34 Teva Pharmaveutical Industries Ltd.: Revenue Mix (2013) (%) 59
Figure 35 Contribution Of Speciality Medicine Segment Towards Company Revenues, 2008-2013 (USD MN) 60
Figure 36 Actavis Plc: Revenue Mix (2013) (%) 62

【レポートのキーワード】

子宮内避妊器具

★調査レポート[北米の子宮内避妊器具市場] (コード:MMM-IN-1000)販売に関する免責事項を必ずご確認ください。
★調査レポート[北米の子宮内避妊器具市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆